However, it exhibited promising activity in earlier studies from improving cognitive health through modulation of the SIRT1 pathway in the brain of a diabetes-induced cognitive dysfunction mouse model, and remains promising for DMD therapy (Yang et al., 2021). This evidence concerns the gene SIRT1 and Duchenne muscular dystrophy.